Mark L. Moster

3.5k total citations
99 papers, 1.6k citations indexed

About

Mark L. Moster is a scholar working on Ophthalmology, Neurology and Molecular Biology. According to data from OpenAlex, Mark L. Moster has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Ophthalmology, 30 papers in Neurology and 23 papers in Molecular Biology. Recurrent topics in Mark L. Moster's work include Glaucoma and retinal disorders (17 papers), Ophthalmology and Eye Disorders (14 papers) and Cerebral Venous Sinus Thrombosis (13 papers). Mark L. Moster is often cited by papers focused on Glaucoma and retinal disorders (17 papers), Ophthalmology and Eye Disorders (14 papers) and Cerebral Venous Sinus Thrombosis (13 papers). Mark L. Moster collaborates with scholars based in United States, Italy and France. Mark L. Moster's co-authors include Robert C. Sergott, Thomas M. Bosley, Steven Galetta, Gary Goldberg, Peter J. Savino, Nicholas J. Volpe, Laura J. Balcer, Norman J. Schatz, Valérie Biousse and Grant T. Liu and has published in prestigious journals such as Neurology, Annals of Neurology and Biological Psychiatry.

In The Last Decade

Mark L. Moster

90 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Moster United States 23 699 610 301 297 210 99 1.6k
Gregory S. Kosmorsky United States 25 668 1.0× 636 1.0× 270 0.9× 423 1.4× 156 0.7× 85 1.8k
Dean M. Cestari United States 21 534 0.8× 479 0.8× 307 1.0× 236 0.8× 227 1.1× 89 1.6k
Robert L. Tomsak United States 25 566 0.8× 600 1.0× 160 0.5× 480 1.6× 170 0.8× 83 1.7k
Paul W. Brazis United States 25 764 1.1× 355 0.6× 234 0.8× 422 1.4× 81 0.4× 69 1.4k
Rosa A. Tang United States 22 573 0.8× 915 1.5× 111 0.4× 813 2.7× 282 1.3× 82 1.9k
Lenworth N. Johnson United States 20 598 0.9× 790 1.3× 119 0.4× 160 0.5× 105 0.5× 51 1.5k
Jeffrey G. Odel United States 25 391 0.6× 1.1k 1.9× 180 0.6× 438 1.5× 591 2.8× 83 2.0k
James Acheson United Kingdom 22 395 0.6× 541 0.9× 95 0.3× 157 0.5× 128 0.6× 63 1.3k
John W. Simon United States 28 395 0.6× 1.3k 2.1× 525 1.7× 889 3.0× 224 1.1× 122 2.4k
Jorge C. Kattah United States 26 1.4k 2.0× 849 1.4× 366 1.2× 1.2k 3.9× 129 0.6× 119 3.2k

Countries citing papers authored by Mark L. Moster

Since Specialization
Citations

This map shows the geographic impact of Mark L. Moster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Moster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Moster more than expected).

Fields of papers citing papers by Mark L. Moster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Moster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Moster. The network helps show where Mark L. Moster may publish in the future.

Co-authorship network of co-authors of Mark L. Moster

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Moster. A scholar is included among the top collaborators of Mark L. Moster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Moster. Mark L. Moster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moster, Mark L., Robert C. Sergott, Nancy J. Newman, et al.. (2021). Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies. Journal of Neuro-Ophthalmology. 41(3). 298–308. 4 indexed citations
2.
Yu‐Wai‐Man, Patrick, Nancy J. Newman, Valério Carelli, et al.. (2021). Evaluation of the efficacy of rAAV2/2-ND4 gene therapy for Leber hereditary optic neuropathy compared with the natural history. Investigative Ophthalmology & Visual Science. 62(8). 2676–2676. 1 indexed citations
3.
Biousse, Valérie, Nancy J. Newman, Patrick Yu‐Wai‐Man, et al.. (2020). Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. Journal of Neuro-Ophthalmology. 41(3). 309–315. 43 indexed citations
4.
Yu‐Wai‐Man, Patrick, Mark L. Moster, Alfredo A. Sadun, et al.. (2019). rAAV2/2-ND4 for the Treatment of Leber Hereditary Optic Neuropathy (LHON): 72-Week Data from the REVERSE Phase III Clinical Trial. Investigative Ophthalmology & Visual Science. 60(9). 4806–4806. 2 indexed citations
5.
Moster, Mark L., Alfredo A. Sadun, Thomas Klopstock, et al.. (2019). rAAV2/2-ND4 for the Treatment of LHON: 72-week Data from the REVERSE Phase III Clinical Trial (Plen02.002). Neurology. 92(15_supplement). 3 indexed citations
6.
Shin, Robert K., Luis J. Mejico, Aki Kawasaki, et al.. (2015). Transient Ocular Motor Nerve Palsies Associated With Presumed Cranial Nerve Schwannomas. Journal of Neuro-Ophthalmology. 35(2). 139–143. 9 indexed citations
7.
Fraser, Clare L., et al.. (2015). Of grave concern. Survey of Ophthalmology. 62(1). 96–102. 5 indexed citations
8.
Hills, William L., Marjorie R. Grafe, Jane L. Weissman, et al.. (2014). Homonymous Hemianopia Due to Erdheim–Chester Disease. Journal of Neuro-Ophthalmology. 34(3). 237–242. 3 indexed citations
9.
Bennett, Jeffrey L., Molly Nickerson, Fiona Costello, et al.. (2014). Re-evaluating the treatment of acute optic neuritis. Journal of Neurology Neurosurgery & Psychiatry. 86(7). 799–808. 26 indexed citations
10.
Levin, Marc H., Sriram Venneti, Mark L. Moster, et al.. (2012). Optic Nerve Biopsy in the Management of Progressive Optic Neuropathy. Journal of Neuro-Ophthalmology. 32(4). 313–320. 13 indexed citations
11.
Volpe, Nicholas J., et al.. (2009). Computerized Binocular Pupillography of the Swinging Flashlight Test Detects Afferent Pupillary Defects. Current Eye Research. 34(7). 606–613. 10 indexed citations
12.
Ko, Melissa W., Peter E. Turkeltaub, Edward B. Lee, et al.. (2009). Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis. Journal of the Neurological Sciences. 278(1-2). 127–131. 16 indexed citations
13.
Jacobs, Dina, et al.. (2009). Intracranial Malignancies Occurring More Than 20 Years After Radiation Therapy for Pituitary Adenoma. Journal of Neuro-Ophthalmology. 29(4). 289–295. 20 indexed citations
14.
Moster, Mark L. & Laura J. Balcer. (2004). The 56th Annual Meeting of the American Academy of Neurology, San Francisco, California, April 24-30, 2004. Journal of Neuro-Ophthalmology. 24(4). 327–336.
15.
Chaiamnuay, Sumapa, et al.. (2003). Successful Management of a Pregnant Woman with a TSH Secreting Pituitary Adenoma with Surgical and Medical Therapy. Pituitary. 6(2). 109–113. 24 indexed citations
16.
Moster, Mark L. & Michele H. Johnson. (1998). A neuro-ophthalmologist's perspective on neuroradiology. Seminars in Ultrasound CT and MRI. 19(3). 216–224.
17.
Kupersmith, Mark J., et al.. (1996). Beneficial Effects of Corticosteroids on Ocular Myasthenia Gravis. Archives of Neurology. 53(8). 802–804. 69 indexed citations
18.
Buček, Ján, L Pospíśil, Mark L. Moster, & Boris Skalka. (1992). Experimental Dermatophilosis. Journal of Veterinary Medicine Series B. 39(1-10). 495–502. 2 indexed citations
19.
Bosley, Thomas M., Motohiro Kiyosawa, Mark L. Moster, et al.. (1991). Neuro-Imaging and Positron Emission Tomography of Congenital Homonymous Hemianopsia. American Journal of Ophthalmology. 111(4). 413–418. 10 indexed citations
20.
Moster, Mark L. & Eugene M. Hoenig. (1989). Spasm of the near reflex associated with metabolic encephalopathy. Neurology. 39(1). 150–150. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026